[In vivo dosimetry in interstitial "low dose rate" afterloading therapy with Ir-192 seeds exemplified with head-neck tumors].
An in vivo measuring method is introduced from mending the calculated lying time of implants corresponding to the given dose (reference dose) in the interstitial brachytherapy with iridium-192 seeds. The small effort for using this method and the relatively easy way of handling it allow its clinical use for quality assurance in brachytherapy.
Sadat Khonsari
A
A
Institut für Radiologie, Universität Erlangen-Nürnberg.
Grabenbauer
G
G
Müller
R G
RG
Säbel
M
M
D001918:Brachytherapy / Q000295:instrumentation / Q000379:methods*; D002138:Calibration; D005459:Fluorides; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D007496:Iridium Radioisotopes / Q000008:administration & dosage*; D008094:Lithium; D018020:Lithium Compounds; D008961:Models, Structural; D009060:Mouth Floor; D009062:Mouth Neoplasms / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D013819:Thermoluminescent Dosimetry / Q000295:instrumentation / Q000379:methods*
D007496:Iridium Radioisotopes; D018020:Lithium Compounds; C027651:lithium fluoride; D008094:Lithium; D005459:Fluorides
In-vivo-Dosimetrie bei interstitieller "low dose rate"-Afterloadingtherapie mit Ir-192-Seeds am Beispiel von Kopf-Hals-Tumoren.